SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Sigmund Freud

PatientSigmund Freud
Date of birth1952-05-06
IdentifiersMRN HR-ET005-SYN; SSN (made up) 000-05-8403
Document date2026-07-13
AuthorAnton Reinholt, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-week review: cutting down, setting a quit date, pain and weight. [S]

History of Present Illness

Mr. Freud returns six weeks after intake. He smokes about six cigars a day and has chosen a quit date one week from today. The quitline has called him three times. The nausea stopped once he took varenicline after food, and the dreams are milder. The relined obturator seals better: liquids leak into his nose only now and then, and his speech is clearer. The sore spot had healed by the two-week check at the prosthodontics clinic. Dr. Vasquez-Lindqvist took impressions for the new obturator last week. The speech-language therapy sessions have not started because the first appointment was cancelled. His pain is 4 of 10 and he is eating more. [S]

ElementDetail
CigarsAbout six a day; quit date one week from today
Varenicline1 mg twice daily after food; no nausea; milder dreams
QuitlineThree calls
Pain4 of 10
Weight58.9 kg

Review of Systems

SystemResultFinding
ConstitutionalNegativeEating more; no fever
Ears, nose, mouth, and throatPositiveOccasional nasal leakage of liquids; sore spot healed; no bleeding or lump
RespiratoryPositiveMorning cough, less than before
PsychiatricNegativeMood steady; some irritability on low-cigar days

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four daysOne tablet daily for three days, then twice daily for four days, after foodOral route2026-06-01 to 2026-06-08completedS
Varenicline 1 mg oral tablet, one tablet twice daily after food; planned for at least 24 weeksOne tablet twice daily after foodOral route2026-06-08activeS
Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain at the maxillectomy siteTwo tablets three times dailyOral route2026-06-01activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-07-13Body height172cmS
2026-07-13Body weight58.9kgS
2026-07-13Body mass index (BMI) [Ratio]19.9kg/m2S
2026-07-13Systolic blood pressure134mm[Hg]S
2026-07-13Diastolic blood pressure80mm[Hg]S
2026-07-13Heart rate76/minS
2026-07-13Respiratory rate16/minS
2026-07-13Body temperature36.6CelS
2026-07-13Oxygen saturation in Arterial blood by Pulse oximetry96%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-07-13Pain severity in the past week - 0-10 numeric rating [Reported]4{score}S

Physical Exam

Vital signs recorded on 2026-07-13; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 134/80, pulse 76; weight 58.9 kg
MouthWith the obturator out: ulcer at the defect margin healed; no mass, induration or white or red patch
NeckNo lymph nodes felt
SpeechMild hypernasality with the relined obturator

Problems

ProblemClinical statusVerificationCodeProvenance
Tobacco use disorder, severe: about twenty cigars a day for about fifty years, with many failed attempts to stop; synthetic modern episode linked to his documented cigar smokingactiveconfirmed F17.290S — Synthetic modern coding; person-first language; not a claim about his real diagnosis.
Squamous cell carcinoma of the right hard and soft palate seven years ago, treated by right partial maxillectomy with clear margins (pT2 N0) and no radiation in this synthetic history, with no recurrence on yearly surveillanceactiveconfirmed Z85.818S — Synthetic modern survivorship coding anchored to his documented 1923 cancer and operation; the modern stage and treatment are synthetic.
Acquired defect of the right maxilla and palate after maxillectomy, closed with an obturator prosthesis that is now worn and fits poorlyactiveconfirmed Z90.09S — Synthetic modern coding anchored to his documented obturator.
Hypernasal speech and nasal leakage of liquids from a poorly sealing obturatoractiveconfirmed R49.21S — Synthetic finding; resolved when the new obturator was fitted.
Chronic pain at the maxillectomy site and right cheek, worse where the obturator rubsactiveconfirmed G89.29S — Synthetic modern coding anchored to his documented constant mouth pain.
Raised LDL cholesterol (126 mg/dL) with a high estimated 10-year cardiovascular risk after fifty years of smokingactiveconfirmed E78.5S — Synthetic finding on the intake lipid panel.
Weight loss of 4 kg in six months from painful chewing and leakage, with a low albuminactiveconfirmed R63.4S — Synthetic finding; resolved as weight and albumin recovered.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyTobacco use (cigars a day), readiness and quit dateEvery visitCompleted todayAbout six cigars a day; quit date in one week
Medication safetyVarenicline adherence and side effects (nausea, sleep, dreams, mood)Every visit; at least 12 weeks, extended to 24 weeks or moreCompleted todayNo nausea after food; milder dreams; mood steady
Medication safetyCombination nicotine replacement (patch and lozenge)From the quit date for at least 8 to 12 weeksOrdered21 mg patch and 4 mg lozenge from the quit date
Self-managementBehavioral support (quitline and clinic sessions)Weekly calls around the quit date, then every two to four weeksCompleted todayThree quitline calls since enrollment; weekly calls around the quit date
ExaminationHead and neck surveillance examination (mouth, defect and neck)Yearly by his head and neck surgeon more than five years after treatment; mouth checked at each visitCompleted todayUlcer healed; no mass, induration or white or red patch; neck clear; yearly surgeon's examination booked for next month
ImagingHead and neck imagingOnly for symptoms or signs more than five years after treatmentNot indicatedNo symptoms or signs of recurrence
ExaminationSecond primary cancer counseling and symptom reviewEvery visitCompleted todayNo hoarseness, trouble swallowing, cough with blood or blood in the urine; second primary risk explained again
ExaminationObturator fit, seal and hygieneEvery visitCompleted todayRelined obturator seals better; impressions for the new obturator taken last week
ReferralSpeech and swallowing (hypernasality, nasal leakage)Every visit; speech-language therapy as neededDeferredSpeech-language therapy has not started: the first appointment was cancelled by the clinic and not rebooked. No harm so far: speech is clearer with the reline. Corrective action: rebooked within two weeks, with a reminder call
Self-managementDental care (high-fluoride toothpaste, cleaning every three months)Daily toothpaste; cleaning every three monthsCompleted todayUsing high-fluoride toothpaste nightly; the two root caries found at the consultation were filled by his dentist
ExaminationWeight and nutritionEvery visitCompleted today58.9 kg, up 0.5 kg
SurveyPain score and functionEvery visitCompleted today4 of 10
Medication safetyAcetaminophen daily dose (no more than 3,000 mg)Every visitCompleted today3,000 mg a day
Medication safetyOpioidsAvoid long-term opioidsNot indicatedNot needed

Goal progress:

Guideline basis: Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline (2020); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2026 (follow-up and survivorship) (2026); American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016); CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022)

Follow-up: Quit date in one week, with quitline calls. Speech-language therapy within two weeks. Head and neck surgeon's yearly examination next month. Twelve-week review in six weeks, when the new obturator is fitted. Next scheduled visit 2026-08-24: twelve-week review: five weeks without smoking, the new obturator and survivorship surveillance. [S]